AMIKACIN SULFATE INJECTION USP
MARCAN PHARMACEUTICALS INC
Quick answers
Is there a shortage of AMIKACIN SULFATE INJECTION USP in Canada?
No. There is no current shortage of AMIKACIN SULFATE INJECTION USP 500MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
VPI-AMIKACIN
VPI PHARMACEUTICALS INC
Other Products
AMIKIN
BRISTOL-MYERS SQUIBB CANADA
AMIKACIN SULFATE INJECTION USP
SANDOZ CANADA INCORPORATED
AMIKACIN SULFATE INJECTION
HIKMA CANADA LIMITED
DIN
02481073
Strength
500MG
Dosage Form
Solution
Route
Intravenous Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MARCAN PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02537893
1MG · DIN 02554364
100MG · DIN 00297763
100MG · DIN 02555093
3.5MG · DIN 02493306
150MG · DIN 02546639
1000MG · DIN 02560216
2000MG · DIN 02560224
10MG · DIN 02480530
1MG · DIN 02502623
0.2MG · DIN 02502615
500MG · DIN 02503999